HAYWARD, Calif., Jan. 31 /PRNewswire-FirstCall/ -- Thermage, Inc. , a leader in non-invasive tissue tightening in the aesthetic industry, today announced that it will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference at the Grand Hyatt Hotel in New York City. The Company's presentation is scheduled for 11:00 a.m. Eastern Time on Tuesday, February 6, 2007. Stephen J. Fanning, president and chief executive officer of Thermage, will review the company's business strategy and historical financial results.
Attendance at the conference is by invitation only. Thermage will offer a live audio webcast of its presentation which may be accessed at the Company's website at http://www.thermage.com. An archived replay of the presentation will be available following the live presentation for 14 days and will also be available at http://www.thermage.com.
About Thermage, Inc.
Founded in 1996, Thermage(R), Inc. (Hayward, Calif.) is one of the premier medical device companies dedicated to the development of unique capacitive radiofrequency technologies. Thermage's innovative technology provides the first non-invasive procedure to tighten and contour skin, greatly expanding the aesthetic applications physicians can offer to the booming "anti-aging" market. The company commercially launched its flagship ThermaCool(R) system in 2002 when it received clearance from the U.S. Food & Drug Administration. Today, the ThermaCool system is available in 76 countries; more than 300,000 patients have been treated with Thermage and approximately 2,000 dermatologists, plastic surgeons and other cosmetic physicians are using the Thermage procedure worldwide. For more information about Thermage, call 1-510-259-7117 or log on to http://www.thermage.com.
Thermage, Inc.CONTACT: investors, Douglas Sherk or Jenifer Kirtland, +1-415-896-6820, ormedia, Steve DiMattia, or Jennifer Saunders, +1-646-201-5445, all of EVCGroup, Inc., for Thermage, Inc.
Web site: http://www.thermage.com//
